Cardiovascular Risk Among Adults With Chronic Kidney Disease, With or Without Prior Myocardial Infarction

Journal of the American College of Cardiology

Volumn 48, Issue 6, 2006, Pages 1183-1189

  Wattanakit, Keattiyoat ^a   Coresh, Josef ^b   Muntner, Paul ^c   Marsh, Jane ^b   Folsom, Aaron R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c TULANE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; CORONARY RISK; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; KAPLAN MEIER METHOD; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK ASSESSMENT;

CARDIOVASCULAR DISEASES; CHRONIC DISEASE; FEMALE; HUMANS; INCIDENCE; KIDNEY DISEASES; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX;

EID: 33748413946     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2006.05.047     Document Type: Article

References (35)

1. McCullough P.A. Why is chronic kidney disease the "spoiler" for cardiovascular outcomes?. J Am Coll Cardiol 41 (2003) 725-728
2. Levey A.S., Beto J.A., Coronado B.E., et al. Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis 32 (1998) 853-906
3. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease. Am J Kidney Dis 41 (2003) I-IV S1-91
4. Sarnak M.J., Levey A.S., Schoolwerth A.C., et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108 (2003) 2154-2169
5. Adult Treatment Panel III. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
6. The ARIC Investigators. The Atherosclerosis Risk in Communities (ARIC) study: design and objectives. Am J Epidemiol 129 (1989) 687-702
7. Baecke J.A., Burema J., and Frijters J.E. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36 (1982) 936-942
8. Chambless L.E., Heiss G., Folsom A.R., et al. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the Atherosclerosis Risk in Communities (ARIC) study, 1987-1993. Am J Epidemiol 146 (1997) 483-494
9. Bond M.G., Barnes R.W., Riley W.A., et al. High-resolution B-mode ultrasound scanning methods in the Atherosclerosis Risk in Communities Study (ARIC). J Neuroimaging 1 (1991) 68-73
10. Riley W.A., Barnes R.W., Bond M.G., Evans G., Chambless L.E., and Heiss G. High-resolution B-mode ultrasound reading methods in the Atherosclerosis Risk in Communities (ARIC) cohort. J Neuroimaging 1 (1991) 168-172
11. Eckfeldt J.H., Chambless L.E., and Shen Y.L. Short-term, within-person variability in clinical chemistry test results. Experience from the Atherosclerosis Risk in Communities study. Arch Pathol Lab Med 118 (1994) 496-500
12. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
13. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
14. Coresh J., Astor B.C., McQuillan G., et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am J Kidney Dis 39 (2002) 920-929
15. White A.D., Folsom A.R., Chambless L.E., et al. Community surveillance of coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study: methods and initial two years' experience. J Clin Epidemiol 49 (1996) 223-233
16. Mann J.F., Gerstein H.C., Pogue J., Bosch J., and Yusuf S. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med 134 (2001) 629-636
17. Shulman N.B., Ford C.E., Hall W.D., et al., The Hypertension Detection and Follow-up Program Cooperative Group. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. Hypertension 13 (1989) I80-I93
18. Weiner D.E., Tighiouart H., Stark P.C., et al. Kidney disease as a risk factor for recurrent cardiovascular disease and mortality. Am J Kidney Dis 44 (2004) 198-206
19. Shlipak M.G., Simon J.A., Grady D., et al. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol 38 (2001) 705-711
20. Walsh C.R., O'Donnell C.J., Camargo Jr. C.A., Giugliano R.P., and Lloyd-Jones D.M. Elevated serum creatinine is associated with 1-year mortality after acute myocardial infarction. Am Heart J 144 (2002) 1003-1011
21. Anavekar N.S., McMurray J.J., Velazquez E.J., et al. Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. N Engl J Med 351 (2004) 1285-1295
22. DeBacker G., Ambrosioni E., Borch-Johnsen K., et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 24 (2003) 1601-1610
23. Muntner P., He J., Hamm L., Loria C., and Whelton P.K. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol 13 (2002) 745-753
24. Manjunath G., Tighiouart H., Coresh J., et al. Level of kidney function as a risk factor for cardiovascular outcomes in the elderly. Kidney Int 63 (2003) 1121-1129
25. Manjunath G., Tighiouart H., Ibrahim H., et al. Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41 (2003) 47-55
26. Weiner D.E., Tighiouart H., Amin M.G., et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol 15 (2004) 1307-1315
27. Go A.S., Chertow G.M., Fan D., McCulloch C.E., and Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004) 1296-1305
28. Fried L.F., Shlipak M.G., Crump C., et al. Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol 41 (2003) 1364-1372
29. Al Suwaidi J., Reddan D.N., Williams K., et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation 106 (2002) 974-980
30. Schillaci G., Reboldi G., and Verdecchia P. High-normal serum creatinine concentration is a predictor of cardiovascular risk in essential hypertension. Arch Intern Med 161 (2001) 886-891
31. Shlipak M.G., Sarnak M.J., Katz R., et al. Cystatin C and the risk of death and cardiovascular events among elderly patients. N Engl J Med 352 (2005) 2049-2060
32. Sarnak M.J., Katz R., Stehman-Breen C.O., et al. Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med 142 (2005) 497-505
33. Psaty B.M., Kuller L.H., Bild D., et al. Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study. Ann Epidemiol 5 (1995) 270-277
34. Buccianti G., Baragetti I., Bamonti F., et al. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease. J Nephrol 17 (2004) 405-410
35. Busch M., Franke S., Muller A., et al. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein. Kidney Int 66 (2004) 338-347